Smart drugs
Smart Drugs, also known as noodrive pharmacology, is a scientific discipline focused on the design and synthesis of pharmaceuticals with intrinsic adaptive intelligence, enabling them to autonomously optimise their therapeutic effects within the body.
These drugs leverage embedded nanotechnologies, molecular sensors, and AI-driven biochemical algorithms to dynamically adjust their composition, dosage, and delivery based on real-time physiological data. By interacting with specific biomarkers or environmental cues, smart drugs can target precise tissues, modulate their activity to maximise efficacy, and minimise side effects without external intervention.
Applications include self-regulating treatments for chronic diseases, cancer therapies that adapt to tumour mutations and infection-fighting drugs that evolve against resistant pathogens, all operating with a level of autonomous precision akin to biological systems.
Research
| Tier | 1.400 | A decimal number between 0.0 and ~12.0 indicating the overall level of "advancement" of the science |
|---|---|---|
| Type | Applied | Pure sciences are focused on research and the improvement of knowledge. Applied sciences are too, but to a lesser extent and grant access to more concrete outcomes such as blueprints, governance, and others. |
Aspects
| Physical | Abstract | |
|---|---|---|
| Natural | 5 | 3 |
| Artificial | 3 | 11 |
Aspect tiers heatmap
- 1.9001.470
- 1.9001.470
- 1.9001.470
- 2.9001.400
- 1.9001.470
- 1.9001.470
- 1.9001.470
- 2.9001.400
- 1.9001.470
- 3.9001.330
- 1.9001.470
- 3.9001.330
- 2.9001.400
- 1.9001.470
- 1.9001.470
- 1.9001.470
- 3.9001.330
- 1.9001.470
- 1.9001.470
- 2.9001.400
- 2.9001.400
- 2.9001.400
Blueprints
Coming soon.